FDA approves Eli Lilly’s 2 diabetes drug Mounjaro for obesity under new name, Zepbound.

On Wednesday, the US Food and Drug Administration officially authorized the use of tirzepatide, a medication previously routinely used off-label for weight loss, for the treatment of chronic weight control in people with type 2 diabetes. The medication formerly known…